FDA approves first trial on magic mushrooms as depression treatment

Psilocybin, the active ingredient in 'magic mushrooms' has shown promise for treating depression. Today, the FDA approved the largest trial of the drug globally, and the first in the US.

Source: the Mail online | Health - August 24, 2018 Category: Consumer Health News Source Type: news